RE: the wsj article......
Thanks turtle2001
"Transition Therapeutics's big-pharma partner for its clinical trial bowed out in 2006, so the trial "would have come to a halt," says JDRF's Richard Insel, vice president for research. "We wanted to see this go forward, which meant moving beyond our traditional support for academic research."
Thats hilarious....more like they dragged their feet and was never even in Clinicals......didn't even make it out of Pre-Clinical.....lol